You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brain Metastases in Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Combination use of SRT with T-DXd
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 14, 2023

Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)

Recruiting
  • Breast Cancer With Brain Metastases
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 22, 2023

Breast Cancer Brain Metastases Trial in Guangzhou (SPH4336 Tablets)

Not yet recruiting
  • Breast Cancer Brain Metastases
  • SPH4336 Tablets
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital, Sun Yat-sen University
May 24, 2023

Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Brain Metastases
  • Brain Imaging with 18F-FES
  • New York, New York
    New York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Shanghai (Pyrotinib Plus Capecitabine combined with brain

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Pyrotinib Plus Capecitabine combined with brain radiotherapy
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 14, 2023

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023

Metastatic Breast Cancer Trial in Zhengzhou (SHR-A1811, Pyrotinib, Bevacizumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Mar 13, 2023

Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

Recruiting
  • Breast Cancer Stage IV
  • Datopotamab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023

Metastatic Breast Cancer, Brain Metastases Trial in Tampa (Nivolumab, Stereotactic Radiosurgery)

Active, not recruiting
  • Metastatic Breast Cancer
  • Brain Metastases
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 17, 2022

Brain Metastases, HER2-positive Breast Cancer Trial (Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

Not yet recruiting
  • Brain Metastases
  • HER2-positive Breast Cancer
  • Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine
  • (no location specified)
Jan 10, 2023

Brain Metastases, HR+ Metastatic Breast Cancer Trial in Tampa (Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy)

Recruiting
  • Brain Metastases
  • HR+ Metastatic Breast Cancer
  • Stereotactic Radiosurgery (SRS)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Nov 1, 2022

Mammary Tumors, Human Trial in Tianjin (eutidrone etoposide bevacizumab)

Recruiting
  • Mammary Neoplasms, Human
  • eutidrone etoposide bevacizumab
  • Tianjin, Tianjin, China
    Yehui Shi
Mar 10, 2023

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)

Recruiting
  • Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Sep 15, 2022

Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)

Recruiting
  • Metastatic HER2 Negative Breast Carcinoma
  • +3 more
  • UTD1 combined with capecitabine
  • Changsha, China
    Quchang Ouyang
Sep 9, 2022

A Nationwide Multicenter, Ambispective Real-world Study of

Recruiting
  • Breast Cancer
    • Zhengzhou, Henan, China
      Henan cancer hospital
    Sep 15, 2022

    Brain Metastases, Breast Cancer Trial in Palo Alto (QBS72S)

    Not yet recruiting
    • Brain Metastases
    • Breast Cancer
    • Palo Alto, California
      Stanford Cancer Institute
    Jun 29, 2022

    T-Dxd in Treatment of HER2-positive BCBM After Prior Pyrotinib

    Recruiting
    • Breast Cancer
    • Beijing, Beijing, China
    • +1 more
    Nov 13, 2023

    Breast Cancer Stage IV Trial in Vienna (Trastuzumab deruxtecan)

    Active, not recruiting
    • Breast Cancer Stage IV
    • Trastuzumab deruxtecan
    • Vienna, Austria
      AKH Universitaetsklinikum Vienna, Department f. Internal medicin
    Jul 26, 2022

    Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

    Recruiting
    • Brain Metastases
    • +2 more
    • Saint Louis, Missouri
    • +1 more
    Nov 8, 2022

    Breast Cancer Trial (Capecitabine and Neratinib.)

    Not yet recruiting
    • Breast Cancer
    • Capecitabine and Neratinib.
    • (no location specified)
    Jul 8, 2022

    Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)

    Withdrawn
    • Breast Cancer
    • +3 more
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Jun 28, 2022

    Triple Negative Breast Cancer, Brain Metastases Trial in Saint Louis (Pembrolizumab, Liposomal Irinotecan)

    Recruiting
    • Triple Negative Breast Cancer
    • Brain Metastases
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 1, 2022

    Metastatic Breast Cancer Trial in New York (Tucatinib)

    Recruiting
    • Metastatic Breast Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 26, 2023

    NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic

    Not yet recruiting
    • NSCLC
    • +5 more
    • single fraction stereotactic radiosurgery (SSRS)
    • fractionated stereotactic radiosurgery (FSRS)
    • (no location specified)
    Jan 18, 2023